Paper26757
Biovailability of phenytoin in lipid containing dosage forms in rats.
Chakrabarti S and 1 other. J Pharm Pharmacol, 1978. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Biovailability of phenytoin in lipid containing dosage forms in rats. Papers, record 26757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26757
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phenytoin | Major topic |
| Administration, Oral | |
| Animals | |
| Biological Availability | |
| Emulsions | |
| Lipids | |
| Male | |
| Rats | |
| Suspensions | |
| Time Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,169,960 | Prediction of Oral Drug Absorption in Rats from In Vitro Data. | Pharm Res | 2023 | https://conductscience.org/library/papers/35169960 | PubMed |
| 30,796,596 | New Insights into Using Lipid Based Suspensions for 'Brick Dust' Molecules: Case Study of Nilotinib. | Pharm Res | 2019 | https://conductscience.org/library/papers/30796596 | PubMed |
| 30,766,791 | Exploring the utility of the Chasing Principle: influence of drug-free SNEDDS composition on solubilization of carvedilol, cinnarizine and R3040 in aqueous suspension. | Acta Pharm Sin B | 2019 | https://conductscience.org/library/papers/30766791 | PubMed |
| 26,597,939 | The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations. | Pharm Res | 2016 | https://conductscience.org/library/papers/26597939 | PubMed |
| 26,579,403 | Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations. | Acta Pharm Sin B | 2014 | https://conductscience.org/library/papers/26579403 | PubMed |
| 24,272,840 | In situ intestinal absorption of a poorly water-soluble drug from mixed micellar solutions of bile salt and lipolysis products in rats. | Pharm Res | 1985 | https://conductscience.org/library/papers/24272840 | PubMed |
| 22,145,101 | Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs. | Sci Pharm | 2011 | https://conductscience.org/library/papers/22145101 | PubMed |
| 18,592,356 | Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis. | Pharm Res | 2008 | https://conductscience.org/library/papers/18592356 | PubMed |
| 8,415,405 | Phenytoin-lipid conjugates: chemical, plasma esterase-mediated, and pancreatic lipase-mediated hydrolysis in vitro. | Pharm Res | 1993 | https://conductscience.org/library/papers/8415405 | PubMed |
| 8,148,213 | Examination of some factors responsible for a food-induced increase in absorption of atovaquone. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/8148213 | PubMed |
| 2,178,317 | Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. | Agents Actions | 1990 | https://conductscience.org/library/papers/2178317 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26757
GET https://conductscience.org/api/papers/v1/26757/authors